Which medication is a platelet aggregation inhibitor?

Study for the NCLEX Pharmacology Cardiovascular Drugs Test. Explore multiple choice questions with detailed explanations and hints. Prepare confidently for your NCLEX exam!

Multiple Choice

Which medication is a platelet aggregation inhibitor?

Explanation:
The main concept is how platelet aggregation inhibitors differ from anticoagulants. Clopidogrel works by blocking the P2Y12 ADP receptor on platelets, which prevents ADP-mediated activation of the glycoprotein IIb/IIIa complex and thus stops platelets from sticking together. This antiplatelet action directly reduces platelet aggregation, which is key in arterial thrombosis and in preventing events like heart attacks. The other medications are anticoagulants that work on the coagulation cascade rather than platelets: heparin enhances antithrombin III to inhibit thrombin and factor Xa; warfarin inhibits vitamin K-dependent clotting factor synthesis; enoxaparin mainly inhibits factor Xa with some anti-thrombin effects. So, clopidogrel is the platelet aggregation inhibitor.

The main concept is how platelet aggregation inhibitors differ from anticoagulants. Clopidogrel works by blocking the P2Y12 ADP receptor on platelets, which prevents ADP-mediated activation of the glycoprotein IIb/IIIa complex and thus stops platelets from sticking together. This antiplatelet action directly reduces platelet aggregation, which is key in arterial thrombosis and in preventing events like heart attacks. The other medications are anticoagulants that work on the coagulation cascade rather than platelets: heparin enhances antithrombin III to inhibit thrombin and factor Xa; warfarin inhibits vitamin K-dependent clotting factor synthesis; enoxaparin mainly inhibits factor Xa with some anti-thrombin effects. So, clopidogrel is the platelet aggregation inhibitor.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy